JSMC
Jess S. Morgan & Co’s Axsome Therapeutics AXSM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | $3.52M | Sell |
78,895
-25,994
| -25% | -$1.16M | 3.06% | 15 |
|
2022
Q2 | $4.02M | Sell |
104,889
-2,298
| -2% | -$88K | 4.17% | 8 |
|
2022
Q1 | $4.44M | Sell |
107,187
-7,338
| -6% | -$304K | 3.23% | 8 |
|
2021
Q4 | $4.33M | Buy |
114,525
+1,095
| +1% | +$41.4K | 2.66% | 22 |
|
2021
Q3 | $3.74M | Buy |
113,430
+45,595
| +67% | +$1.5M | 2.47% | 32 |
|
2021
Q2 | $4.58M | Buy |
67,835
+15,177
| +29% | +$1.02M | 3.01% | 11 |
|
2021
Q1 | $2.98M | Buy |
52,658
+8,190
| +18% | +$464K | 2.09% | 31 |
|
2020
Q4 | $3.62M | Buy |
44,468
+5,450
| +14% | +$444K | 2.89% | 16 |
|
2020
Q3 | $2.78M | Sell |
39,018
-310
| -0.8% | -$22.1K | 2.77% | 17 |
|
2020
Q2 | $3.24M | Sell |
39,328
-3,074
| -7% | -$253K | 3.51% | 5 |
|
2020
Q1 | $2.5M | Buy |
42,402
+36,902
| +671% | +$2.17M | 3.24% | 16 |
|
2019
Q4 | $568K | Buy |
+5,500
| New | +$568K | 0.56% | 37 |
|